| Lot Release Number |
2021-08-26-0449
|
| FDA Registered Product/Generic Name |
BEVACIZUMAB
|
| Brand Name |
AVASTIN
|
| Dosage Strength |
25 mg/mL (400 mg/16 mL)
|
| Dosage Form |
CONCENTRATE FOR SOLUTION FOR I.V. INFUSION
|
| Registration Number |
BR-969
|
| Batch/Lot Number |
B7271
|
| Packaging Lot |
Packaging Lot (Box):B7271B01
|
| Product Expiration Date |
3 June 2023
|
| Issuance Date |
31 August 2021
|